Ann: FDA grants Orphan for both Phelan-McDermid and Pitt Hopkins, page-46

And this is where it hard establish what NEU is worth

$2B today sure seems fantasy given current MC

Look at potential pipeline of drugs and revenue, $2B sale looks cheap for Neu

If Phase 3 is unsuccessful then we are worth zip!

As I have noted before I can’t see how management would accept anything less than $10-$20

recent reports supported by management indicate their view of current valuation 6 + months ago being $4-6 dollar range

I think a recent poster pointed out IPO listing price for Neu many years back was 50cents old money $5 today’s money, surely these holder potentially including LW want a nice return on that

Looks like we are more or less going to get close to end of Phase 3 trial before there maybe potential offer which is all or nothing

in the meantime this will be $4 shortly as we draw closer to trial